Adivo is a seed startup based in Germany. 1 investor tracked on Brouky Intelligence. Status: acquired. Data sourced from Brouky Intelligence.
About
Adivo develops species-specific antibodies for innovative veterinary therapies.
Stage
seed
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky